John B Buse Selected Research

John B Buse Research Topics

Disease

171	Type 2 Diabetes Mellitus (MODY) 01/2024 - 07/2002
41	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 07/2009
38	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 06/2008
31	Stroke (Strokes) 01/2024 - 11/2002
30	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 07/2010
29	Myocardial Infarction 01/2024 - 11/2002
23	Heart Failure 11/2023 - 08/2003
21	Body Weight (Weight, Body) 01/2024 - 01/2007
19	Hyperglycemia 12/2021 - 01/2002
18	COVID-19 05/2024 - 01/2021
15	Weight Loss (Weight Reduction) 01/2023 - 11/2004
12	Chronic Renal Insufficiency 01/2023 - 11/2018
11	Nausea 01/2023 - 07/2009
9	Neoplasms (Cancer) 12/2023 - 07/2011
9	Dyslipidemias (Dyslipidemia) 01/2022 - 07/2002
8	Infections 03/2024 - 09/2018
8	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 09/2015
8	Weight Gain 01/2019 - 06/2009
7	Pancreatitis 01/2018 - 07/2011
6	Obesity 10/2023 - 03/2005
6	Diabetes Mellitus 11/2020 - 02/2003
6	Insulin Resistance 01/2018 - 06/2003
5	Peripheral Arterial Disease 01/2023 - 01/2018
5	Ketosis 01/2022 - 09/2015
5	Acute Coronary Syndrome 01/2020 - 09/2013
5	Unstable Angina 12/2019 - 04/2010
4	Post-Acute COVID-19 Syndrome 05/2024 - 12/2022
4	Diarrhea 01/2023 - 01/2011
4	Hypertension (High Blood Pressure) 01/2022 - 02/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 04/2016
4	Vomiting 09/2015 - 01/2011
4	Inflammation (Inflammations) 09/2013 - 06/2011
3	Overweight 10/2023 - 03/2016
3	Kidney Diseases (Kidney Disease) 11/2022 - 01/2018
3	Albuminuria 01/2022 - 01/2021
3	Diabetes Complications 10/2019 - 06/2018
3	Glucose Intolerance 04/2010 - 01/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2021
2	Headache (Headaches) 01/2023 - 01/2011

Drug/Important Bio-Agent (IBA)

73	Insulin (Novolin)FDA Link 01/2023 - 06/2003
68	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2002
40	Liraglutide FDA Link 01/2022 - 07/2009
32	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 01/2004
26	Insulin Glargine (Lantus)FDA Link 01/2022 - 06/2009
22	Exenatide (Byetta)FDA Link 01/2020 - 07/2003
18	Glucagon-Like Peptide-1 ReceptorIBA 03/2024 - 07/2009
18	omega-Chloroacetophenone (Mace)IBA 01/2024 - 07/2011
18	LipidsIBA 01/2020 - 01/2004
17	Blood Glucose (Blood Sugar)IBA 01/2024 - 07/2015
17	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023 - 01/2013
16	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 01/2007
16	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 07/2003
16	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 10/2008
15	semaglutideIBA 01/2023 - 01/2019
15	insulin degludecIBA 11/2021 - 11/2014
14	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 07/2015
13	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022 - 07/2015
11	Sodium-Glucose Transport ProteinsIBA 01/2021 - 07/2015
9	SodiumIBA 03/2024 - 11/2018
8	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 07/2015
8	IncretinsIBA 01/2018 - 11/2004
7	Fluvoxamine (Luvox)FDA LinkGeneric 10/2023 - 01/2022
7	Ivermectin (Mectizan)FDA Link 10/2023 - 01/2022
7	Hemoglobins (Hemoglobin)IBA 11/2021 - 05/2009
7	Pioglitazone (Actos)FDA Link 01/2019 - 01/2004
6	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021 - 07/2015
6	CreatinineIBA 01/2021 - 01/2017
6	Fenofibrate (CiL)FDA LinkGeneric 01/2020 - 04/2010
6	Triglycerides (Triacylglycerol)IBA 01/2017 - 07/2002
5	Insulin Lispro (Humalog)FDA Link 01/2022 - 05/2009
5	ThiazolidinedionesIBA 11/2020 - 08/2003
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 08/2005
5	Fibric Acids (Fibrates)IBA 01/2020 - 06/2007
5	HDL CholesterolIBA 01/2017 - 07/2002
5	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2011 - 01/2004
4	KetonesIBA 01/2021 - 09/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 06/2007
4	LDL CholesterolIBA 01/2020 - 11/2007
4	aleglitazarIBA 01/2018 - 09/2013
4	Rosiglitazone (Avandia)FDA Link 07/2009 - 01/2004
3	GlucokinaseIBA 01/2022 - 01/2019
3	TTP399IBA 01/2022 - 01/2019
3	Peptides (Polypeptides)IBA 04/2021 - 09/2009
3	SymportersIBA 11/2020 - 11/2018
3	AlbuminsIBA 01/2020 - 01/2020
3	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 07/2002
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 07/2002
3	IDegLiraIBA 10/2015 - 11/2014
3	Lipoproteins (Lipoprotein)IBA 08/2013 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 07/2012 - 01/2007
3	1,5-anhydroglucitolIBA 06/2012 - 06/2006
2	Antiviral Agents (Antivirals)IBA 05/2024 - 06/2023
2	dulaglutideIBA 01/2024 - 01/2021

Therapy/Procedure

61	Therapeutics 03/2024 - 01/2004
36	Glycemic Control 01/2023 - 01/2004
9	Injections 01/2021 - 07/2010
6	Surgical Amputation (Amputations) 10/2021 - 11/2002
3	Subcutaneous Injections 01/2024 - 01/2017
2	Artificial Respiration (Mechanical Ventilation) 03/2024 - 11/2022
2	Drug Therapy (Chemotherapy) 12/2023 - 01/2002